Literature DB >> 34570622

A permutation test for assessing the presence of individual differences in treatment effects.

Chi Chang1, Thomas Jaki2, Muhammad Saad Sadiq3, Alena Kuhlemeier4, Daniel Feaster3, Natalie Cole4, Andrea Lamont5, Daniel Oberski6, Yasin Desai7, M Lee Van Horn4.   

Abstract

An important goal of personalized medicine is to identify heterogeneity in treatment effects and then use that heterogeneity to target the intervention to those most likely to benefit. Heterogeneity is assessed using the predicted individual treatment effects framework, and a permutation test is proposed to establish if significant heterogeneity is present given the covariates and predictive model or algorithm used for predicted individual treatment effects. We first show evidence for heterogeneity in the effects of treatment across an illustrative example data set. We then use simulations with two different predictive methods (linear regression model and Random Forests) to show that the permutation test has adequate type-I error control. Next, we use an example dataset as the basis for simulations to demonstrate the ability of the permutation test to find heterogeneity in treatment effects for a predicted individual treatment effects estimate as a function of both effect size and sample size. We find that the proposed test has good power for detecting heterogeneity in treatment effects when the heterogeneity was due primarily to a single predictor, or when it was spread across the predictors. Power was found to be greater for predictions from a linear model than from random forests. This non-parametric permutation test can be used to test for significant differences across individuals in predicted individual treatment effects obtained with a given set of covariates using any predictive method with no additional assumptions.

Entities:  

Keywords:  Predicted individual treatment effects; Random Forests; heterogeneity in treatment effects; permutation test; personalized medicine

Mesh:

Year:  2021        PMID: 34570622     DOI: 10.1177/09622802211033640

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  2 in total

Review 1.  Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.

Authors:  Christina N Fournier
Journal:  Neurotherapeutics       Date:  2022-07-11       Impact factor: 6.088

2.  A permutation procedure to detect heterogeneous treatment effects in randomized clinical trials while controlling the type I error rate.

Authors:  Jack M Wolf; Joseph S Koopmeiners; David M Vock
Journal:  Clin Trials       Date:  2022-05-09       Impact factor: 2.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.